ScoreWhy is Assembly Biosciences, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.78% and Operating profit at 12.64% over the last 5 years
2
The company has declared Positive results for the last 11 consecutive quarters
- NET SALES(HY) Higher at USD 50.68 MM
- NET PROFIT(HY) Higher at USD 13.01 MM
- ROCE(HY) Highest at -5.66%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 42.59%, its profits have risen by 84.8%
4
High Institutional Holdings at 93.53%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Consistent Returns over the last 3 years
- Along with generating 42.59% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Assembly Biosciences, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Assembly Biosciences, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Assembly Biosciences, Inc.
42.59%
1.09
55.70%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.78%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-68.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.34
Sales to Capital Employed (avg)
0.73
Tax Ratio
0.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
93.53%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.13
EV to EBIT
-15.83
EV to EBITDA
-16.00
EV to Capital Employed
-4.70
EV to Sales
2.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-2.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
NET SALES(HY)
Higher at USD 50.68 MM
NET PROFIT(HY)
Higher at USD 13.01 MM
ROCE(HY)
Highest at -5.66%
RAW MATERIAL COST(Y)
Fallen by -0.03% (YoY
CASH AND EQV(HY)
Highest at USD 474.71 MM
-13What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -9.08 MM has Fallen at -493.2%
NET PROFIT(Q)
At USD -9.08 MM has Fallen at -493.2%
DEBT-EQUITY RATIO
(HY)
Highest at -112.84 %
NET SALES(Q)
Lowest at USD 8.21 MM
OPERATING PROFIT(Q)
Lowest at USD -11.34 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -138.12 %
Here's what is working for Assembly Biosciences, Inc.
Cash and Eqv
Highest at USD 474.71 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -0.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Assembly Biosciences, Inc.
Net Sales
At USD 8.21 MM has Fallen at -54.56%
over average net sales of the previous four periods of USD 18.08 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -9.08 MM has Fallen at -493.2%
over average net sales of the previous four periods of USD -1.53 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -9.08 MM has Fallen at -493.2%
over average net sales of the previous four periods of USD -1.53 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
Lowest at USD 8.21 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit
Lowest at USD -11.34 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -138.12 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at -112.84 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
